GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cleopatra Hospital Co (CAI:CLHO) » Definitions » Beneish M-Score

Cleopatra Hospital Co (CAI:CLHO) Beneish M-Score : -2.29 (As of Apr. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Cleopatra Hospital Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.29 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Cleopatra Hospital Co's Beneish M-Score or its related term are showing as below:

CAI:CLHO' s Beneish M-Score Range Over the Past 10 Years
Min: -3.35   Med: -2.29   Max: 0.78
Current: -2.29

During the past 9 years, the highest Beneish M-Score of Cleopatra Hospital Co was 0.78. The lowest was -3.35. And the median was -2.29.


Cleopatra Hospital Co Beneish M-Score Historical Data

The historical data trend for Cleopatra Hospital Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleopatra Hospital Co Beneish M-Score Chart

Cleopatra Hospital Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -2.52 0.78 -3.35 -3.08 -2.29

Cleopatra Hospital Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.08 -2.55 -1.76 -2.48 -2.29

Competitive Comparison of Cleopatra Hospital Co's Beneish M-Score

For the Medical Care Facilities subindustry, Cleopatra Hospital Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cleopatra Hospital Co's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cleopatra Hospital Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Cleopatra Hospital Co's Beneish M-Score falls into.



Cleopatra Hospital Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Cleopatra Hospital Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.2266+0.528 * 1.0028+0.404 * 0.6931+0.892 * 1.3753+0.115 * 1.1795
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1936+4.679 * -0.031151-0.327 * 1.2296
=-2.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was E£1,117 Mil.
Revenue was 1063.252 + 947.511 + 807.685 + 776.852 = E£3,595 Mil.
Gross Profit was 365.92 + 320.971 + 256.537 + 263.512 = E£1,207 Mil.
Total Current Assets was E£1,767 Mil.
Total Assets was E£4,488 Mil.
Property, Plant and Equipment(Net PPE) was E£2,310 Mil.
Depreciation, Depletion and Amortization(DDA) was E£181 Mil.
Selling, General, & Admin. Expense(SGA) was E£157 Mil.
Total Current Liabilities was E£1,431 Mil.
Long-Term Debt & Capital Lease Obligation was E£509 Mil.
Net Income was 107.221 + 119.721 + 96.619 + 94.593 = E£418 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = E£0 Mil.
Cash Flow from Operations was 161.155 + 238.429 + 6.562 + 151.816 = E£558 Mil.
Total Receivables was E£662 Mil.
Revenue was 712.192 + 660.553 + 604.604 + 636.905 = E£2,614 Mil.
Gross Profit was 238.909 + 223.775 + 195.439 + 221.951 = E£880 Mil.
Total Current Assets was E£1,116 Mil.
Total Assets was E£3,264 Mil.
Property, Plant and Equipment(Net PPE) was E£1,716 Mil.
Depreciation, Depletion and Amortization(DDA) was E£161 Mil.
Selling, General, & Admin. Expense(SGA) was E£95 Mil.
Total Current Liabilities was E£904 Mil.
Long-Term Debt & Capital Lease Obligation was E£243 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1117.232 / 3595.3) / (662.301 / 2614.254)
=0.310748 / 0.253342
=1.2266

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(880.074 / 2614.254) / (1206.94 / 3595.3)
=0.336644 / 0.335699
=1.0028

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1767.127 + 2309.783) / 4488.027) / (1 - (1116.465 + 1716.419) / 3264.343)
=0.091603 / 0.132173
=0.6931

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3595.3 / 2614.254
=1.3753

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(161.15 / (161.15 + 1716.419)) / (181.275 / (181.275 + 2309.783))
=0.085829 / 0.07277
=1.1795

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(156.641 / 3595.3) / (95.426 / 2614.254)
=0.043568 / 0.036502
=1.1936

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((508.892 + 1431.058) / 4488.027) / ((243.492 + 904.051) / 3264.343)
=0.43225 / 0.351539
=1.2296

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(418.154 - 0 - 557.962) / 4488.027
=-0.031151

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Cleopatra Hospital Co has a M-score of -2.29 suggests that the company is unlikely to be a manipulator.


Cleopatra Hospital Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Cleopatra Hospital Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Cleopatra Hospital Co (CAI:CLHO) Business Description

Traded in Other Exchanges
N/A
Address
39 Cleopatra street, Opposite Maidan Salahuddin Square Almazah, Heliopolis, Cairo, EGY
Cleopatra Hospital Co is a private hospital in Egypt. The company provides health and medical services, as well as the medical care of inpatients. Its operating segment based on hospitals includes Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawi Hospital, Al Shorouk Hospital, CHG for Medical Services, CHG Pharma for pharmacies management, CHG for Hospitals, Queens Hospitals and Al Kateb Hospitals. It generates maximum revenue from the Cleopatra Hospital Company segment. The company derives revenue from Accommodation and medical supervision, Surgeries, Outpatient clinics, Laboratories, Cardiac catheterization, Service charge, Radiology, Emergency, Oncology center, Pharmacy, Dentistry, Physiotherapy, Endoscopy, Cardiac tests, and Other services.

Cleopatra Hospital Co (CAI:CLHO) Headlines

No Headlines